Algert Global LLC Seagen Inc. Transaction History

Algert Global LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$117.37 - $139.17 $64,436 - $76,404	549 Added 25.39%	2,711 $348,000
Q3 2022 Nov 15, 2022	BUY	$135.27 - $180.11 $292,453 - $389,397	2,162 New	2,162 $296,000
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $191,396 - $315,441	-1,759 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $210,393 - $277,658	1,759 New	1,759 $253,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.